“蹭热点式”布局“脑机接口”业务?亚辉龙遭监管警示

Core Viewpoint - The current "brain-computer interface" is a market hotspot, attracting significant investor attention, particularly after the company's stock price rose by 6.52% with a trading volume increase of 299% compared to the previous trading day. The company is urged to ensure that disclosures related to this hot topic are accurate and complete to avoid misleading investors [2] Group 1: Regulatory Actions - The Shanghai Stock Exchange issued a regulatory warning to the company, highlighting inconsistencies in the announcement regarding the technical path of its partner and insufficient risk disclosures related to collaboration uncertainties [2] - Following the announcement of a strategic cooperation framework agreement with Shenzhen Brain Machine Starlink Technology Co., Ltd., the company faced immediate media scrutiny and market attention [2][3] Group 2: Partnership Details - The company clarified that the current research products of Brain Machine Starlink are based on a non-invasive technical path, with no invasive technology in development, and that some products are still in early research or pre-clinical stages [3] - The company plans to invest no more than 15 million yuan in Brain Machine Starlink, with an estimated research and development investment of around 30 million yuan for the related projects, which are still in early stages and have uncertain development timelines [3] Group 3: Financial Performance - For the first three quarters of 2025, the company's revenue was approximately 1.287 billion yuan, a year-on-year decrease of 7.69%, while net profit was about 60.42 million yuan, down 72.36% year-on-year. The company reported cash and cash equivalents of 465 million yuan [4]

Shenzhen YHLO Biotech -“蹭热点式”布局“脑机接口”业务?亚辉龙遭监管警示 - Reportify